Group B Streptococcal Cellulitis-Adenitis Syndrome in Infants: Insights From 24 Years of Experience

Area of Science:

• Neonatal infectious diseases
• Pediatric dermatology
• Bacterial pathogenesis

Background:

• Group B Streptococcus (GBS) is a leading cause of neonatal infections.
• Invasive GBS disease encompasses various clinical presentations, including sepsis, meningitis, and pneumonia.
• Cellulitis-adenitis represents a less common but significant manifestation of invasive GBS disease in neonates.

Observation:

• A retrospective review identified 28 infants diagnosed with GBS cellulitis-adenitis over 24 years.
• The study analyzed clinical features, diagnostic methods, treatment approaches, and patient outcomes.
• This rare condition presented with characteristic skin and lymph node inflammation.

Findings:

• Early recognition of GBS cellulitis-adenitis is crucial for timely intervention.
• The spectrum of findings includes localized erythema, swelling, and regional lymphadenopathy.
• Optimal management involves prompt antibiotic therapy and supportive care, leading to favorable outcomes in most cases.

Implications:

• Understanding the clinical nuances of GBS cellulitis-adenitis aids pediatricians and neonatologists in prompt diagnosis.
• This rare manifestation highlights the diverse presentations of invasive GBS disease.
• Effective management strategies can prevent complications and improve infant health outcomes.